| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945410 Administered to treat postmanopausal osteoporosis, low bone turnover osteoporosis, osteomalacia and renal osteodystrophy |
| 08/31/1999 | US5945300 Polypeptides with dna(rna) encoding and genetic engineering |
| 08/31/1999 | US5945119 A plastic strip having microporous material impregnated with cesium chloride and magnesium sulfate on both side as antiarthritic agent or treatment of other soft tissue injuries; antiinflammatory agents |
| 08/31/1999 | US5945102 Crustacean and fish derived multifunctional enzyme |
| 08/31/1999 | CA2175179C Non-aqueous emollient iodophor formulations |
| 08/31/1999 | CA2141765C Stabilized ascorbic acid containing emulsion; cosmetic treatment process using said emulsion and other uses |
| 08/31/1999 | CA2006028C Cosmetic or pharmaceutical composition containing polymers or fatty bodies microspheres with at least one active ingredient |
| 08/26/1999 | WO1999042578A2 Modulation of cell proliferation, methods and reagents |
| 08/26/1999 | WO1999042481A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042146A1 Products comprising fibrinogen for use in therapy |
| 08/26/1999 | WO1999042132A1 Use of anti-cd44 monoclonal antibody to enhance wound healing |
| 08/26/1999 | WO1999042131A1 Skin care compositions |
| 08/26/1999 | WO1999042105A1 Epimorphian compound and its use |
| 08/26/1999 | WO1999042101A1 Dietary control of arachidonic acid metabolism |
| 08/26/1999 | WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 08/26/1999 | WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 08/26/1999 | DE19909251A1 Agents for treating human diseases, particularly cancer, modulate interaction of beta-catenin with transcription factors or tumor suppressor gene products |
| 08/26/1999 | DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors |
| 08/26/1999 | CA2357015A1 Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | CA2320219A1 Products comprising fibrinogen for use in therapy |
| 08/26/1999 | CA2320060A1 Skin care compositions |
| 08/26/1999 | CA2318959A1 Epimorphian compound and its use |
| 08/26/1999 | CA2318811A1 Modulation of cell proliferation, methods and reagents |
| 08/25/1999 | EP0937463A1 Skin care compositions |
| 08/25/1999 | EP0937394A1 Antimicrobial composition |
| 08/25/1999 | EP0937143A2 Secreted proteins and polynucleotides encoding them |
| 08/25/1999 | EP0937103A2 Compounds and methods for modulating cell adhesion |
| 08/25/1999 | EP0937075A1 New imidazopyridines and oxazolopyridines |
| 08/25/1999 | EP0937069A1 Piperazino derivatives as neurokinin antagonists |
| 08/25/1999 | EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 08/25/1999 | EP0937038A1 Vitamin d analogues |
| 08/25/1999 | EP0936900A2 Aqueous, antimicrobial liquid cleaning formulation |
| 08/25/1999 | EP0936897A1 Composition having tanning and sun-screening activity, and cosmetic uses thereof |
| 08/25/1999 | EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor |
| 08/25/1999 | CN1226835A -i gene transfer methods for wound healing |
| 08/25/1999 | CN1226440A Medicine for psoriasis and preparing method thereof |
| 08/25/1999 | CN1226427A External used Chinese medicine liquid prepared from plants, method and use thereof |
| 08/24/1999 | US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof |
| 08/24/1999 | US5942531 Phenolic/naphtholic retinoids for promoting skin/exoskeleton pigmentation |
| 08/24/1999 | US5942233 Herbal composition for stimulating blood circulation |
| 08/24/1999 | US5942231 Daily bathing in a bathtub with a water-permeable bag containing the dry powder of guava leaves; treatment of allergic diseases |
| 08/24/1999 | CA2180944C Method for delipidation of skin and cerumen removal |
| 08/24/1999 | CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/24/1999 | CA2015197C Phenolic amine depigmenting and antimelanoma agents |
| 08/24/1999 | CA1340715C Bovine interleukin-1b |
| 08/19/1999 | WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 08/19/1999 | WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 08/19/1999 | WO1999040910A1 Anti-inflammatory agents |
| 08/19/1999 | WO1999032098A3 Combination of a ramba and a tocopherol |
| 08/19/1999 | WO1999031141A3 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof |
| 08/19/1999 | WO1999031125B1 Wound healing compositions |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1999025380A3 Methods and compositions for the treatment of psoriasis |
| 08/19/1999 | WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/19/1999 | CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | CA2320285A1 Anti-inflammatory agents |
| 08/19/1999 | CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 08/19/1999 | CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935463A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof |
| 08/18/1999 | EP0896537B1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 08/18/1999 | CN1226338A Method of improving skin condition |
| 08/18/1999 | CN1225834A Liniment |
| 08/18/1999 | CN1225828A External-use medicine for treating burn and scald of humanbody |
| 08/18/1999 | CN1225825A Capsule of peenisetum flaccidum for treating acne and preparing method therefor |
| 08/17/1999 | US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof |
| 08/17/1999 | US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists |
| 08/17/1999 | US5939427 Lotion with 17-allyl-1,4-dihydroxy-12-(2-(4-hydroxy-3-methoxy cyclohexyl)-1-methylvinyl)-23,25-dimethoxy-13,19,21,27-tetrame thyl-11,28-dioxa-4-azatricyclo(22.3.1.0(4,9))octacos-18-ene-1, 3,10,16-tetraone or salt as antiinflammatory agent |
| 08/17/1999 | US5939415 A!-annellated pyrrole derivatives and their use in pharmacology |
| 08/17/1999 | US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies |
| 08/17/1999 | US5939409 Processes for the production of anti-inflammatory steroids |
| 08/17/1999 | US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents |
| 08/17/1999 | US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 08/17/1999 | US5939090 Gel formulations for topical drug delivery |
| 08/17/1999 | CA2147594C Procedure for the obtainment of 1-(5-bromofur-2-il)-2-bromo-2-nitroethene and its microcide action |
| 08/13/1999 | CA2260279A1 Transparent dandruff shampoos |
| 08/12/1999 | WO1999040220A2 Method of screening therapeutic agents |
| 08/12/1999 | WO1999040111A1 The aiolos gene |
| 08/12/1999 | WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 08/12/1999 | WO1999040089A1 Benzothiadiazoles and derivatives |
| 08/12/1999 | WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 08/12/1999 | WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use |
| 08/12/1999 | WO1999040083A2 Bifunctional tryptase inhibitors |
| 08/12/1999 | WO1999040080A1 Hydroxamic and carboxylic acid derivatives |
| 08/12/1999 | WO1999040073A2 Tryptase inhibitors |
| 08/12/1999 | WO1999039682A2 Lipid mixtures and their use |
| 08/12/1999 | WO1999031233A8 Polypeptides, polynucleotides and uses thereof |
| 08/12/1999 | WO1999029339A3 Prevention and/or treatment of allergic conditions |
| 08/12/1999 | WO1999003446A3 Antimicrobial cosmetic compositions |
| 08/12/1999 | WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 08/12/1999 | WO1998053850A3 Compositions and means for the treatment of burns and other cutaneous traumas |
| 08/12/1999 | CA2321175A1 Method of screening therapeutic agents |
| 08/12/1999 | CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 08/12/1999 | CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |